KR101426232B1 - Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component - Google Patents
Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component Download PDFInfo
- Publication number
- KR101426232B1 KR101426232B1 KR1020120067866A KR20120067866A KR101426232B1 KR 101426232 B1 KR101426232 B1 KR 101426232B1 KR 1020120067866 A KR1020120067866 A KR 1020120067866A KR 20120067866 A KR20120067866 A KR 20120067866A KR 101426232 B1 KR101426232 B1 KR 101426232B1
- Authority
- KR
- South Korea
- Prior art keywords
- mycelium
- extract
- cosmetic composition
- rice
- cream
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 239000002537 cosmetic Substances 0.000 title claims abstract description 37
- 240000007594 Oryza sativa Species 0.000 title claims description 47
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 46
- 235000009566 rice Nutrition 0.000 title claims description 32
- 241001556385 Sanghuangporus baumii Species 0.000 title claims description 14
- 235000013376 functional food Nutrition 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000006071 cream Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- -1 pack Substances 0.000 claims description 15
- 239000006210 lotion Substances 0.000 claims description 13
- 230000009471 action Effects 0.000 claims description 10
- 235000016709 nutrition Nutrition 0.000 claims description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 235000020778 linoleic acid Nutrition 0.000 claims description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims 1
- 239000004464 cereal grain Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 44
- 238000009472 formulation Methods 0.000 description 26
- 241000371652 Curvularia clavata Species 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 18
- 150000004665 fatty acids Chemical class 0.000 description 15
- 235000013305 food Nutrition 0.000 description 13
- 239000000049 pigment Substances 0.000 description 13
- 235000007189 Oryza longistaminata Nutrition 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 241000123107 Phellinus Species 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000000686 essence Substances 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940079894 benzophenone-9 Drugs 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229950011392 sorbitan stearate Drugs 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000014679 Morus rubra var. rubra Nutrition 0.000 description 2
- 235000014677 Morus rubra var. tomentosa Nutrition 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 240000007582 Corylus avellana Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000002195 Nymphaea caerulea Nutrition 0.000 description 1
- 244000058734 Nymphaea stellata Species 0.000 description 1
- 235000016428 Nymphaea stellata Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000746966 Zizania Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- WKZFQFQFYZJKPR-UHFFFAOYSA-N butanedioic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)CCC(O)=O WKZFQFQFYZJKPR-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000014508 negative regulation of coagulation Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- LRBQNJMCXXYXIU-YIILYMKVSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)C(OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-YIILYMKVSA-N 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 상황버섯 균사체 배양미 추출물을 유효성분으로 함유하는 화장료 조성물 및 기능성 식품에 관한 것으로, 더욱 상세하게는 상황버섯 균사체 배양미 추출물을 함유함으로써 우수한 수렴 효과로 피부 조직을 조밀하게 하여 모공 수축 작용 등의 효과가 증진되는 것을 특징으로 하는 화장료 조성물 또는 기능성 식품에 관한 것이다.The present invention relates to a cosmetic composition and a functional food containing an extract of Phellinus linteus mycelium cultured as an active ingredient and more particularly to a cosmetic composition and a functional food containing a pancreatic mycelial culture extract, And the like. The present invention also relates to a cosmetic composition or a functional food.
Description
본 발명은 상황버섯 균사체 배양미 추출물을 유효성분으로 함유하는 화장료 조성물 및 기능성 식품에 관한 것으로, 더욱 상세하게는 상황버섯 균사체 배양미 추출물을 함유함으로써 피부 수렴 효과가 증진되는 것을 특징으로 하는 화장료 조성물 및 기능성 식품에 관한 것이다.The present invention relates to a cosmetic composition and a functional food containing an extract of Phellinus linteus mycelium cultured as an active ingredient and more particularly to a cosmetic composition and a cosmetic composition, Functional food.
1990년대 초반까지는 빵, 라면 등 밀가루를 중심으로 한 간편식품이 현대인들에게 폭발적인 인기를 유지하였다. 당시 시대적 상황은 빠르게 먹을 수 있는 음식이 대세였고, 음식의 기호도에 대한 관심이 많아 밀가루 음식의 선호도가 높았다. 1990년대 급격한 경제성장과 더불어 소비자들의 생활수준이 향상되고 현대의학의 발전으로 평균수명이 연장되고 고령화 인구가 증가하면서 슬로우 푸드(slow-food), 우리 고유의 먹거리에 대한 관심이 점차적으로 증대되고 있는 추세이다. 이에 따라 밀가루보다 영양성분, 생리활성 물질 및 유용성분 함량이 높고, 소화장애가 적은 쌀을 가공한 제품에 대한 관심이 증대되고 있는 추세이다.Until the early 1990s, simple foods such as bread, ramen, and other flour remained an explosive popularity among modern people. At that time, the food was quick to eat, and there was a lot of interest in the preference of the food, so the preference of flour was high. With the rapid economic growth in the 1990s, consumers' interest in slow food and our own food has been increasing steadily as the living standards of consumers have improved, the life expectancy has been extended due to the development of modern medicine, and the aging population has increased Trend. Accordingly, there is a growing interest in products that have higher nutritional, physiologically active, and useful ingredient contents than flour and processed rice with less digestive disorders.
국내 쌀 생산량은 2000년대 들어서면서부터 공급이 수요에 비하여 크게 증가하여, 잉여 자원이 많이 발생하였다. 최근 과잉생산된 쌀의 소비처가 마땅치 않아 정부차원에서도 대책마련에 부심하고 있다. 쌀을 이용한 상품들 중 쌀 소비가 많은 상품으로는 식사용 쌀과 양조용 쌀인데, 식사용 쌀은 햇가족화의 영향으로 쌀 소비 촉진이 어렵고, 양조용 쌀은 쌀을 이용한 약주나 탁주의 맛이 소비자들의 기대에 못미치고 있는 단점이 있다. 따라서 쌀을 유용한 미생물로 발효한 기능성 상품개발에 대한 관심이 증대하고 있어, 다양한 균들의 작용에 따른 쌀의 소화율 향상, 기능성 향상 및 제품 다변화에 대한 기대가 증가하고 있다. 최근에는 웰빙 열풍으로 건강에 대한 관심이 고조되어 있을 뿐만 아니라 만성질환의 예방을 위해서 기능성 식품에 대한 요구가 나날이 커짐에 따라 기능성 식품의 개발이 현대 식품산업의 주된 과제로 떠오르고 있다. 따라서 천연소재를 이용한 건강 지향적 제품 개발이 진행되고 있으며 식품의 기능성에 대한 연구도 활발히 수행되고 있다.Domestic rice production has increased significantly since 2000, when the supply of rice has increased compared to demand, and surplus resources have been generated. Recently, the consumption of rice, which is overproduced, is not enough, and the government is trying to prepare measures. Among the products using rice, rice with a high consumption of rice is rice for eating rice and rice for rice, rice for consumption is difficult to stimulate consumption of rice due to the influence of hatched familyization, rice for rice is used for rice wine, It has the disadvantage that it is below the expectations of consumers. Therefore, there is a growing interest in the development of functional products fermented with useful microorganisms for rice, and the expectation for improvement of rice digestibility, functional improvement and product diversification due to the action of various microorganisms is increasing. In recent years, there has been a growing interest in health due to the well-being craze, and the demand for functional foods has been increasing for the prevention of chronic diseases, and thus the development of functional foods has become a major task of the modern food industry. Therefore, development of health - oriented products using natural materials is progressing, and studies on the functionality of foods are actively carried out.
흑미(Oryza sative, Black Rice)는 쌀겨층에 자홍색의 색소를 가지고 있는 쌀로 주요 생산지는 중국이나 동남아시아 지역이고 우리나라의 경우도 진도, 해남, 보성 등 일부지역에서 생산되고 있다. 또한 흑미는 단백질, 식물성지방, 섬유소, 무기질, 비타민 등 영양성분이 풍부하고 항산화 활성과 항변이원성 같은 생리활성 효과가 높다고 알려져 있으며 항산화 성분으로는 cyanidin 3-O-β-ㅇ-glucoside, peonidin3-O-β-ㅇ-glucoside 등이 보고되었다. 일반적으로 적색 및 검정색을 나타내는 과일과 채소 등에 많이 함유된 안토시아닌은 항산화력이 높은 물질로 알려져 있다.Black rice ( Oryza sative , Black Rice) is rice with pigment of magenta in rice bran layer. Its main producing area is China or Southeast Asia, and Korea is also produced in some areas such as Jindo, Haenam and Boseong. In addition, black rice is rich in nutrients such as protein, vegetable fat, fiber, minerals and vitamins, and is known to have high antioxidant and antimutagenic effects. Antioxidants include cyanidin 3-O-β-glucoside, peonidin3-O -β-o-glucoside have been reported. Anthocyanins, commonly found in red and black fruits and vegetables, are known to be highly antioxidant.
적미(Oryza sative, Red Rice)는 서아시아 지역에서 많이 생산되는 야생종 벼에 가까운 쌀로써, 적갈색의 색소를 지니고 있으며, 이들 적색소의 성분은 열에도 비교적 안정적이며 특히 산성조건에서도 안전하게 이용될 수 있는 cyanidin-3-glucoside로 구성되어 있다. 또한, 적미는 안토시안(anthocyan) 색소를 다량으로 함유하고 있으며, 안토시안 색소를 가진 유색미는 비 안토시안 색소를 가진 유색미에 비하여 강한 항산화 효과가 있는 것으로 보고되고 있다. 특히 쌀겨 부분에 안토시안과 함께 카테킨이라 불리우는 카테콜 탄닌(catechol tannin)을 다량 함유하고 있어, 이것에 의한 항산화작용이 주목받고 있다. 그 이유는 산화 스트레스에 의한 여러 가지 질환들이 카테킨(catechin)과 비타민 E, superoxide dismutase(SOD), 카탈라제(catalase), glutathione peroxidase(GSH-Px) 등의 항산화 작용에 의하여 예방되는 것으로 알려져 있기 때문이며, 특히 지질대사와 관련하여 항산화효소 및 항산화 비타민이 지질대사를 개선하고 있는 것이 잘 알려져 있기 때문이다. Oryza sative (Red Rice) is a rice similar to wild rice species produced in West Asia region. It has a reddish brown pigment. These red rice ingredients are relatively stable even in heat and can be safely used even in acidic conditions. Cyanidin- 3-glucoside. In addition, red rice contains a large amount of anthocyan pigments, and pigments with anthocyan pigments have been reported to have a stronger antioxidative effect than pigments with nonanthocyan pigments. Particularly, rice bran contains a large amount of catechol tannin called anthocyanin and catechin, and the antioxidative action by this is attracting attention. This is because various diseases caused by oxidative stress are known to be prevented by antioxidant activities of catechin, vitamin E, superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px) In particular, it is well known that antioxidant enzymes and antioxidant vitamins improve lipid metabolism in relation to lipid metabolism.
버섯류는 세계적으로 약 20,000여 종이 알려져 있으며 그 중 식용으로 개발 가능한 것은 약 2,000여 종이다. 국내 분포하는 버섯류는 약 992종이 기록되어 있고 이중 식용 버섯이 100여 종, 독버섯이 50여 종이며, 특히 맹독성을 가진 버섯이 20여 종으로 확인되어있다. 약 20여 종 이상의 버섯이 국내에서 재배가능하며 항암, 콜레스테롤 저하, 혈당강하 등이 입증된 바 있다. 전 세계적으로 상황버섯은 약 280여 종류가 존재한다. 대부분의 상황버섯은 노란색을 띠며 나이테 무늬를 형성하며 성장하는데, 현재 가장 널리 인공 재배되는 버섯 품종 중의 하나이다. 상황버섯 중 대표적인 것은 목질진흙버섯으로 Phellinus linteus라는 학명으로 알려져 있다. 그러나, 한국의 경우 대표적인 재배종은 바우미 상황버섯(Phellinus baumii)으로 전체 상황 배재 농가의 98% 이상을 차지하고 있다. 특이하게 바우미 상황버섯이 식용으로 허용되고 건강증진 식품으로 활용되는 곳은 한국이 유일한 것으로 알려져 있으며, 현재까지 상황버섯으로부터 다양한 생리활성물질들의 분리 연구가 지속적으로 진행되고 있으며, 추출방법에 따른 상황버섯 추출물의 효능변화 및 평가가 검토되고 있다. 자실체 이외에 균사체에서도, 상황버섯 자실체와 유사한 혈액 항응고 활성, 항산화 효과, 항암작용, 위궤양 완화효과 및 항염증작용, 알츠하이머(alzheimer) 질환 치료를 위한 β-secretase 저해활성 등의 다양한 생리활성이 보고되면서 상황버섯의 균사체 배양에 많은 연구가 집중되고 있다. 피부자극감소와 기능성분 증강을 위하여 본 발명에서는 기능성 쌀에 유색미와 Phellinus baumii(상황버섯) 균사를 배양하여 기능성 식품 및 천연화장품 원료로 활용하고자 한다.About 20,000 species of mushrooms are known worldwide, of which about 2,000 species can be developed for food. Approximately 992 species of mushrooms distributed in Korea are recorded. Among them, about 100 kinds of edible mushrooms and 50 kinds of mushrooms are found. Especially, more than 20 kinds of mushrooms having high toxicity are identified. More than 20 kinds of mushrooms can be cultivated in Korea, and have been proven to have anti-cancer, low cholesterol and low blood sugar. There are about 280 kinds of mushrooms around the world. Most of the mushrooms grow in yellow and form a ring pattern, which is one of the most widely artificially grown mushroom cultivars. A typical example of the situation mushroom is woody mud mushroom Phellinus It is known as linteus . However, in Korea, a representative cultivar is Bormi situation mushroom ( Phellinus baumii ) accounts for more than 98% of the total dismantled farm households. Unusually, it is known that Korea is the only place where it is allowed to be edible and used as a health promotion food. So far, various studies on the separation of physiologically active substances from mushrooms have been continuously conducted, Changes in the efficacy and evaluation of mushroom extracts are under review. Various mycelial activities such as blood anticoagulant activity, antioxidant activity, anticancer activity, gastric ulcer relaxation effect and anti-inflammatory activity similar to those of mushroom fruiting body and β-secretase inhibitory activity for treating Alzheimer disease have been reported in mycelium in addition to fruiting bodies Much research has been focused on the mycelial culture of mushrooms. In order to reduce skin irritation and to enhance functional ingredients, the present invention uses functional pigments such as Phellinus baumii (situation mushroom) hypha is cultured to utilize as functional food and natural cosmetics raw material.
한국등록특허 제0946584호에는 지실 추출물 및 블루로터스 추출물을 함유하는 수렴 및 피부 자극 완화용 화장료 조성물이 개시되어 있고, 한국등록특허 제0829720호에는 복분자 추출물을 유효성분으로 함유하는 수렴 화장료 조성물이 개시되어 있으나, 본 발명의 상황버섯 균사체 배양미 추출물을 함유하는 수렴 화장료 조성물과는 상이하다.Korean Patent Registration No. 0946584 discloses a cosmetic composition for astringent and skin irritation alleviation containing a root extract and a blue lotus extract, and Korean Patent No. 0829720 discloses a astringent cosmetic composition containing an extract of bokbunja as an active ingredient However, it differs from the astringent cosmetic composition containing the extract of the mushroom cultured mycelium of the present invention.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 일반미 또는 유색미 추출물에 비해 수렴활성 효과가 현저하게 우수한 상황버섯 균사체 배양미 추출물을 함유하는 화장료 조성물 및 기능성 식품을 제공함으로써 본 발명을 완성하였다.The present invention has been made in view of the above needs, and it is an object of the present invention to provide a cosmetic composition and a functional food containing the extract of a mushroom mycelium cultivar which is remarkably excellent in astringent activity compared with a general or coloring matter extract, Respectively.
상기 과제를 해결하기 위해, 본 발명은 상황버섯(Phellinus baumii) 균사체 배양미 추출물을 유효성분으로 함유하는 피부 수렴 작용을 갖는 화장료 조성물을 제공한다.In order to solve the above problems, the present invention Phellinus (Phellinus The present invention provides a cosmetic composition having a skin-converging action containing, as an active ingredient, an extract of a mycelium of Mycobacterium tuberculosis .
또한, 본 발명은 상황버섯(Phellinus baumii) 균사체 배양미 추출물을 유효성분으로 함유하는 피부 수렴 작용을 갖는 기능성 식품을 제공한다.In addition, the present invention relates to a method for producing a mushroom The present invention provides a functional food having a skin-converging action containing an extract of Mycelium mycelium as an active ingredient.
본 발명에 따르면, 상황버섯 균사체 배양미 추출물을 함유한 화장료 조성물은 수렴활성 효과가 현저하게 우수하며, 식물로부터 얻어진 생리활성물질을 함유하기 때문에 그 효과가 뛰어나고 부작용을 유발하지 않은 화장료 조성물을 제공할 수 있다.According to the present invention, there is provided a cosmetic composition which is excellent in its effect because it contains a physiologically active substance obtained from plants and has remarkably excellent convergence activity effect, and which does not cause side effects .
또한, 본원 발명의 방법으로 상황버섯 균사체 배양미를 추출하여 활성성분의 함량을 극대화시키고 불순물을 제거하여 안정도가 향상됨과 동시에 효능이 극대화된 추출물을 피부 외용제, 예컨대 가용화 기술을 이용한 유연화장수에서부터 유화기술을 응용한 영양화장수, 크림, 에센스 등에 첨가할 수 있을 뿐만 아니라, 피부 수렴을 위한 기능성 식품 등에 사용될 수 있다.In addition, the method of the present invention extracts cultured mushroom mycelia to maximize the content of the active ingredient, remove impurities to improve the stability, and maximize the efficacy of the extract to a skin external preparation, for example, , Cream, essence, etc., as well as functional foods for skin astringency.
도 1은 상황버섯 균사체(JMI-P2), 상황버섯 균사체 배양적미(RRCP) 및 상황버섯 균사체 배양흑미(BRCP)를 보여준다.
도 2는 쌀 추출물 및 상황버섯 균사체 배양미 추출물의 농도에 따른 흑생종 세포(B16F10) 생존율을 나타낸 그래프이다.
red: 적미 추출물, RRCP: 상황버섯 균사체 배양적미 추출물, black: 흑미 추출물, BRCP: 상황버섯 균사체 배양흑미 추출물
도 3은 쌀 추출물 및 상황버섯 균사체 배양미 추출물의 농도에 따른 섬유아세포(fibroblast cell) 생존율을 나타낸 그래프이다.
red: 적미 추출물, RRCP: 상황버섯 균사체 배양적미 추출물, black: 흑미 추출물, BRCP: 상황버섯 균사체 배양흑미 추출물
도 4는 쌀 추출물 및 상황버섯 균사체 배양미 추출물의 농도에 따른 수렴 활성을 비교한 그래프이다.
Red rice: 적미 추출물, RRCP: 상황버섯 균사체 배양적미 추출물, Black rice: 흑미 추출물, BRCP: 상황버섯 균사체 배양흑미 추출물Figure 1 shows the mycelia mycelium (JMI-P2), mycelium culture mycelium culture (RRCP) and cultured mycelium culture broth (BRCP).
FIG. 2 is a graph showing the survival rate of the melanoma cells (B16F10) according to the concentration of rice extract and rice bran cultured mycelium extract.
red: Red mulberry extract, RRCP: Culture of mycelium of mycelia of mushroom, black: Black rice extract, BRCP: Mycelium of mushroom culture black rice extract
FIG. 3 is a graph showing the survival rate of fibroblast cells according to the concentration of rice extract and rice bran cultured mycelium extract. FIG.
red: Red mulberry extract, RRCP: Culture of mycelium of mycelia of mushroom, black: Black rice extract, BRCP: Mycelium of mushroom culture black rice extract
FIG. 4 is a graph comparing the convergent activities of the extracts of the rice extract and the mushroom mycelium cultured according to their concentrations. FIG.
Red rice: Rip roots extract, RRCP: Culture of mycelia of mycelia, Black rice: Black rice extract, BRCP: Black mushroom cultivation mycelium culture
본 발명의 목적을 달성하기 위하여, 본 발명은 상황버섯(Phellinus baumii) 균사체 배양미 추출물을 유효성분으로 함유하는 피부 수렴 작용을 갖는 화장료 조성물을 제공한다.According to an aspect of the invention, the invention is Phellinus (Phellinus The present invention provides a cosmetic composition having a skin-converging action containing, as an active ingredient, an extract of a mycelium of Mycobacterium tuberculosis .
본 발명의 조성물에서, 상기 상황버섯(Phellinus baumii) 균사체 배양미 추출물은 멸균된 곡물에 상황버섯(Phellinus baumii) 균사체를 접종한 후, 28~32℃에서 배양하여 제조된 상황 균사체 배양미를 동결건조시킨 후 분쇄하고, 에탄올을 첨가하여 추출한 후 45~55℃에서 감압 농축하여 제조될 수 있으며, 바람직하게는 멸균된 곡물에 상황버섯(Phellinus baumii) 균사체를 접종한 후, 30℃에서 배양하여 제조된 상황 균사체 배양미를 동결건조시킨 후 분쇄하고, 에탄올을 첨가하여 추출한 후 50℃에서 감압 농축하여 제조될 수 있으나, 이에 제한되지 않는다.In the composition of the present invention, the above-mentioned mushroom ( Phellinus baumii ) Mycelium extract The situation on the grain sterilized mushroom (Phellinus The mycelia of the mycelium cultured at 28 to 32 ° C after inoculation with mycelium of mycelia can be lyophilized, pulverized, extracted with ethanol, and concentrated under reduced pressure at 45 to 55 ° C. The sterilized cereal was fed with a mushroom ( Phellinus The present invention also relates to a method for producing a mycelium of the present invention, which comprises culturing the mycelia of the mycelia of the present invention cultured at 30 ° C after inoculation of the mycelium with the mycelium of the present invention, lyophilization, pulverization, ethanol extraction and concentration at a reduced pressure at 50 ° C.
본 발명에 따른 상황버섯 균사체 배양미 추출물을 함유하는 화장료 조성물은 조성물 총 중량에 대하여 0.0001~10중량%의 상황버섯 균사체 배양미 추출물을 함유하는 것이 바람직하나 이에 한정되지 않는다.The cosmetic composition containing the mushroom mycelium culture extract according to the present invention preferably contains 0.0001 to 10% by weight of the mushroom mycelium culture extract, based on the total weight of the composition, but is not limited thereto.
본 발명의 상황버섯 균사체 배양미 추출물은 수렴 효과를 갖는 것을 특징으로 하는데, 상황버섯 균사체 배양미 추출물은 다른 쌀 추출물에 비해 높은 수렴활성을 가진다. 따라서, 기존의 쌀 추출물을 이용한 화장료 조성물에 비해 현저하게 높은 피부 수렴 효과를 가지는 것을 특징으로 한다.The mycorrhizae mycelium cultivated extract of the present invention is characterized by having a converging effect, and the rice mushroom mycelium extract has higher convergence activity than other rice extracts. Therefore, it is characterized in that it has remarkably high skin converging effect as compared with the cosmetic composition using the conventional rice extract.
또한, 본 발명의 조성물에서, 상기 화장료는 유연화장수, 수렴화장수, 영양화장수, 영양크림, 마사지크림, 에센스, 아이 크림, 아이 에센스, 클렌징크림, 클렌징 폼, 클렌징워터, 팩, 파우더, 바디로션, 바디크림, 바디오일 및 바디에센스로 이루어진 군으로부터 선택되는 제형을 가질 수 있으나, 이에 제한되지 않는다.Also, in the composition of the present invention, the cosmetic composition can be used as a cosmetic material for cosmetics such as a softener, a cosmetic lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, an eye essence, a cleansing cream, a cleansing foam, a cleansing water, But are not limited to, formulations selected from the group consisting of body creams, body oils, and body essences.
본 발명의 화장료 조성물에 포함되는 성분은 유효 성분으로서의 상황버섯 균사체 배아미 추출물 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The ingredients contained in the cosmetic composition of the present invention include components commonly used in cosmetic compositions in addition to the extract of the mushroom mycelium extract as an active ingredient and can be prepared by conventional methods such as antioxidants, stabilizers, solubilizers, vitamins, Supplements, and carriers.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수(스킨), 영양 화장수(밀크로션), 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used as a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, , Oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it can be manufactured in the form of a flexible lotion (skin), a nutritional lotion (milk lotion), a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder .
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters.
본 발명은 또한, 상황버섯(Phellinus baumii) 균사체 배양미 추출물을 유효성분으로 함유하는 피부 수렴 작용을 갖는 기능성 식품을 제공한다.The invention also Phellinus (Phellinus The present invention provides a functional food having a skin-converging action containing an extract of Mycelium mycelium as an active ingredient.
본 발명의 상기 상황버섯 균사체 배양미 추출물을 식품첨가물로 사용하는 경우, 상기 추출물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 추출물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.In the case of using the cultured mycelium extract of the present invention as a food additive, the extract may be used as it is, or may be used together with other food or food ingredients, and suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to its intended use (prevention, health or therapeutic treatment). Generally, the extract of the present invention is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight, based on the raw material, in the production of food or beverage. However, in the case of long-term consumption intended for health and hygiene purposes or for health control purposes, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range .
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 기능성 식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the food to which the above substances can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, various soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which contain functional foods in a conventional sense.
본 발명의 기능성 음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.01~0.04 g, 바람직하게는 약 0.02~0.03 g 이다.The functional beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient, such as ordinary beverages. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 상황버섯 균사체 배양미 추출물은 여러가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 상황버섯 균사체 배양미 추출물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 추출물은 100 중량부당 0.01~0.1 중량부의 범위에서 선택되는 것이 일반적이다.
In addition to the above, the extract of Mycelia mycelium cultured according to the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, Glycerin, alcohols, carbonating agents used in carbonated beverages, and the like. In addition, the extract of Mycelium mycelium cultured according to the present invention may contain flesh for the production of natural fruit juice, fruit juice drink and vegetable drink. These components may be used independently or in combination. Although the ratio of such additives is not critical, the extract of the present invention is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
재료 및 방법Materials and methods
1. 실험 재료1. Experimental material
본 실험에는 (재)장흥군버섯산업연구원에서 분양받은 상황(Phellinus baumii)을 사용하였고, 흑미(Oryza sativa, Black Rice)와 적미(Oryza sativa, Red Rice)는 광주 산내들에서 구입하여 사용하였다.In this experiment, Phellinus baumii was used in Jungheung mushroom industry research institute and Oryza sativa (Black Rice) and red rice ( Oryza sativa , Red Rice) were purchased from the Gwangju area.
흑미와 적미를 각각 수세한 후 4시간 동안 수침하고 30분간 물을 뺀 각 곡물을 배양 봉지에 600 g 씩 넣은 후, 121℃에서 15분간 멸균하여 사용하였다. 멸균된 곡물을 방냉한 후 (재)장흥군버섯산업연구원에서 보존 중인 상황(Phellinus baumii) 균사체를 곡물의 표면에 접종하여 배양기의 온도를 30℃로 하여 배양하였다. 배양이 완료된 상황 균사체 배양미를 동결건조시킨 후 초미 분쇄하여 시료로 사용하였고, 안전성과 유효성 검색에는 분쇄한 각각의 시료를 25 g에 80% 에탄올 250 mL를 넣어서 추출한 추출물을 50℃에서 감압 농축하여 약 25 mL로 정용한 후 동결건조하여 사용하였다.
Each of the black rice and red rice was washed with water and then water soaked for 4 hours. After removing water for 30 minutes, 600 g of each grain was put into the culture bag and sterilized at 121 ° C for 15 minutes. After freezing the sterilized grain, the situation is being preserved by Jangheung-gun Mushroom Industry Research Institute ( Phellinus The mycelium was inoculated on the surface of the grains and incubated at a temperature of 30 ° C. For the safety and efficacy screening, each of the ground samples was diluted with 25 mL of 80% ethanol (250 mL) and concentrated under reduced pressure at 50 ° C. After diluting with about 25 mL, it was lyophilized and used.
2. 지방산 분석2. Fatty acid analysis
시료의 지방산은 GC-MS(Agilent 7890A, Palo Alto, CA, USA)를 이용하여 분석하였으며, 분석조건으로 검출기는 Agilent 5975C MSD(Agilent, Palo Alto, CA, USA)를 이용하였으며, column은 DB-WAX column(250 mm L. × 0.25 mm ID., Agilent Co. USA), carrier gas는 헬륨(helium)을 이용하였다. Injection volume은 1.0 mL/min로 시료 1 g을 100 mL의 에테르(ether)를 가하여 100℃의 핫플레이트(hot-plate)로 환류 추출하였다. 추출물을 여과하여 60℃ 항온 수조에서 증발건조한 후 0.5 N methanolic sodium hydroxide 2 mL를 넣고 5분간 환류 추출하였다. 추출 후 14% BF3-메탄올 2 mL를 가해 30분간 환류 추출하였다. 위의 수기에 n-헥산 4 mL를 넣고 2분간 환류 추출 후 포화 염화나트륨(sodium chloride)을 가하여 층이 분리되면 윗층을 취하여 0.45 ㎛ 멤브레인 필터(membrane filter)로 여과하여 분석시료로 사용하였다. 지방산은 GC-MS를 이용하여 분석하며, 표준폼으로는 EC10A-kit(Supelco, USA)를 사용하여 각 peak의 retention time을 확인하였고, GC-MS의 Wiley library의 스펙트럼을 이용하여 동정하였다. 인젝터 온도는 250℃, 칼럼 온도는 140℃에서 2분간 유지한 후 분당 5℃씩 200℃까지 승온시켰고, 250℃까지는 분당 10℃씩 상승시켰다. hold time은 초기에는 50~250℃까지는 10분으로 하였으며, 250℃에서는 4분간으로 조절하여 분석하였다.
The fatty acids of the samples were analyzed by GC-MS (Agilent 7890A, Palo Alto, Calif., USA). The analytical conditions were the Agilent 5975C MSD (Agilent, Palo Alto, CA, USA) WAX column (250 mm L x 0.25 mm ID, manufactured by Agilent Co., USA), and carrier gas was helium. Injection volume was 1.0 mL / min, and 1 g of the sample was added to 100 mL of ether and refluxed with a hot plate at 100 ° C. The extracts were filtered, evaporated to dryness in a constant temperature water bath at 60 ° C, and then 2 mL of 0.5 N methanolic sodium hydroxide was added and refluxed for 5 minutes. After extraction, 2 mL of 14% BF3-methanol was added and the mixture was refluxed for 30 minutes. 4 mL of n-hexane was added to the above solution, and the mixture was refluxed for 2 minutes. After saturated sodium chloride was added, the upper layer was separated and filtered through a 0.45 ㎛ membrane filter. The retention time of each peak was determined using EC10A-kit (Supelco, USA) as a standard form and identified using the spectra of the GC-MS Wiley library. The injector temperature was maintained at 250 ° C and the column temperature was maintained at 140 ° C for 2 minutes. The temperature was increased to 200 ° C at 5 ° C per minute, and then increased to 10 ° C per minute at 250 ° C. The hold time was initially set to 10 minutes from 50 to 250 ° C, and adjusted to 4 minutes at 250 ° C.
3. 안전성과 유효성 검색3. Safety and validity search
가. In vitro에서 안전성 실험end. Safety experiments in vitro
1) 세포주 및 세포 배양법1) Cell line and cell culture method
본 실험에서 사용한 흑색종 세포(melanoma cell)는 B16F10과 섬유아세포(fibroblast cell)는 한국 세포주 은행(Korean cell lines bank)에서 분양받아 사용하였다. 세포는 10% FBS와 antibiotic-antimycotic이 포함된 DMEM(Dulbecco's Modified Eagle Medium) 배지를 사용하였으며, 5% CO2 인큐베이터 37℃에서 배양하였다. 세포를 회수할 때에는 트립신-EDTA 1 mL를 가하여 37℃에서 5분간 반응시켜 세포를 분리하고 배지 4 mL을 넣고 1,200 rpm, 3분간 원심분리하여 세척한 후 실험에 사용하였다.
The melanoma cells used in this study were B16F10 and fibroblast cells were purchased from Korean cell lines bank. Cells were cultured in DMEM (Dulbecco's Modified Eagle Medium) medium containing 10% FBS and antibiotic-antimycotic and incubated at 37 ° C in a 5% CO 2 incubator. When cells were collected, 1 mL of trypsin-EDTA was added, and the cells were separated by incubating at 37 ° C for 5 minutes. 4 mL of the medium was added and centrifuged at 1,200 rpm for 3 minutes.
2) MTT 분석을 이용한 세포 생존율 측정2) Measurement of cell viability using MTT assay
일차적으로 배양한 B16F10 세포와 섬유아세포(fibroblast cell)를 4 × 104 세포/mL로 희석한 다음 96 웰 마이크로플레이트에 0.1 mL/웰씩 분주하여 흑색종 세포(melanoma cell)과 섬유아세포(fibroblast cell)를 5% CO2 조건에서 37℃로 24시간 배양하였다. 그리고 blank에는 0.5% DMSO 200 uL를 넣고, 0.1% DMSO에 용해시킨 각각의 추출물을 1, 2, 5, 10, 25, 50, 100, 200 ㎍/mL 농도로 처리하였다. 24시간 동안 배양 후 배양액을 제거하고 2.5% formazan 용액 50 uL씩을 각 웰에 분주하여 4시간 동안 반응시켜 제거한 다음 100 uL의 DMSO를 가하여 formazan 결정을 용해시켜서 ELISA reader로 540 ㎚에서 흡광도(optical density: OD)를 측정하여 세포생존율(%)을 계산하였다.The primary cultured B16F10 cells and fibroblast cells were diluted to 4 x 10 4 cells / mL, and then plated in 96-well microplates at 0.1 mL / well to obtain melanoma cells and fibroblast cells. Were incubated at 37 ° C for 24 hours under 5% CO 2 . Then, 200 μL of 0.5% DMSO was added to the blank, and each of the extracts dissolved in 0.1% DMSO was treated at 1, 2, 5, 10, 25, 50, 100 and 200 μg / mL. After incubation for 24 hours, the culture solution was removed and 50 μL of 2.5% formazan solution was added to each well. After 4 hours of reaction, 100 μL of DMSO was added to dissolve formazan crystals and the optical density at 540 nm was measured with an ELISA reader. OD) was measured to calculate cell viability (%).
세포 생존율 = (Absorbance of sample-blank/Absorbance of control -blank) x 100
Absorbance of sample-blank / Absorbance of control-
나. 수렴 활성 측정I. Measuring Convergence Activity
수렴(astringent) 활성 측정은 피부 단백질과 유사한 혈액 단백질(hemoglobin)을 사용하여, 원심분리관 용기에 각각의 시료용액과 헤모글로빈 용액을 1:1로 넣어서 진탕 혼합한 다음 1,500 rpm에서 3분간 원심분리 후 576 nm에서 흡광도를 측정하였다. 수렴제 활성 측정은 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다.The astringent activity was measured by using hemoglobin similar to skin protein, mixing each sample solution and hemoglobin solution in a ratio of 1: 1, shaking, centrifuging at 1,500 rpm for 3 minutes Absorbance was measured at 576 nm. The astaxanthin activity measurement was expressed by the absorbance reduction rate of the sample solution addition group and the no addition group.
Astringent activity(%) = (1 - Absorbance of sample/Absorbance of control)×100
Astringent activity (%) = (1 - Absorbance of sample / Absorbance of control) × 100
4. 통계분석4. Statistical Analysis
모든 실험은 시료를 2회 조제하고, 3회 반복 실시하였으며 여기서 얻은 실험결과를 SPSS 통계프로그램 ver 12.0을 이용하여 평균값과 표준편차를 산출하였으며 Duncan's multiple test를 통해 그 유의성 (p<0.05)을 확인하였다.
All samples were prepared twice and repeated 3 times. The mean and standard deviation were calculated using the SPSS statistical program ver. 12.0 and the significance ( p < 0.05) was confirmed by Duncan's multiple test .
실시예Example 1: 상황 균사체 1: situation mycelium 배양미의Cultivated 지방산 조성Fatty acid composition
상황 균사체 배양미의 지방산을 분석한 결과는 표 1에서 보는 바와 같았다. 시료들의 지방산 분석 결과, 리놀레산(linoleic acid), 리놀렌산(linolenic acid)을 비롯하여 팔미트산(palmitic acid) 및 스테아르산(stearic acid) 등 총 7종의 지방산이 검출되었고, 대조구인 적미 및 흑미와 상황배양미의 유의적인 차이를 보인 함량을 나타낸 지방산은 리놀레산(linoleic acid)이였다. 대조구인 적미와 흑미의 지방산 함량에서 차지하는 양은 각각 38.72±1.14 area% 및 36.96±0.29 area%를 나타내었으나, 상황 균사 배양적미와 상황 균사 배양흑미는 각각 47.64±1.07 area%, 38.56±0.17 area%로 나타나, 대조구로 사용된 적미와 흑미에 비하여 지방산 함량이 증가함을 확인하였으며, 전체적으로 배양 전·후 지방산의 함량은 큰 차이를 보이지 않았다.The results of analysis of the fatty acids in the cultured mycelium of the condition were as shown in Table 1. As a result of fatty acid analysis of the samples, seven kinds of fatty acids such as linoleic acid, linolenic acid, palmitic acid and stearic acid were detected, Linoleic acid was the fatty acid which showed the significant difference in cultivation. The amount of fatty acid in the control and the amount of fatty acid in black rice was 38.72 ± 1.14 area and 36.96 ± 0.29 area%, respectively. The content of fatty acid was increased compared to that of control and black rice. The content of fatty acid before and after incubation did not show any significant difference.
1)상황 균사체 배양적미(Red rice cultivated with Phellinus baumii mycelium) 1) Red rice cultivated with Phellinus baumii mycelium)
2)상황 균사체 배양흑미(Black rice cultivated with Phellinus baumii mycelium) 2) Black rice cultivated with Phellinus baumii mycelium)
같은 열(첫번째 윗첨자) 또는 같은 행(마지막 윗첨자) 내의 다른 소문자는 유의적인 차이가 있다(p<0.05).
There is a significant difference ( p <0.05) in the same column (first superscript) or other lower case in the same row (last superscript).
실시예Example 2: 상황 균사체 2: situation mycelium 배양미의Cultivated 폴리페놀 함량 Polyphenol content
실험재료의 폴리페놀 함량은 표 2에서 보는 바와 같이 상황 균사 배양적미 1244.32±11.80 mg/g, 상황 균사 배양흑미 570±1.56 mg/g, 적미 363.88±10.66 mg/g 및 흑미 162.33±2.71 mg/g 순으로 높게 나타났다. 이는 적미 및 흑미에 각각 상황균사체를 배양함으로써 폴리페놀 함량이 더욱 증가한 것으로 보인다.As shown in Table 2, the polyphenol contents of the test materials were 1244.32 ± 11.80 mg / g of the cultured hyphae, 570 ± 1.56 mg / g of red rice, 363.88 ± 10.66 mg / g of red rice, 162.33 ± 2.71 mg / g of black rice Respectively. This suggests that the polyphenol content is further increased by culturing the mycelium of each state in red and black rice.
1)상황 균사체 배양적미(Red rice cultivated with Phellinus baumii mycelium) 1) Red rice cultivated with Phellinus baumii mycelium)
2)상황 균사체 배양흑미(Black rice cultivated with Phellinus baumii mycelium) 2) Black rice cultivated with Phellinus baumii mycelium)
같은 행(윗첨자) 내의 다른 소문자는 유의적인 차이가 있다(p<0.05).
Other lower case letters in the same row (superscript) have significant differences ( p <0.05).
실시예Example 3: 3: InIn vitrovitro 에서 안전성 확인Safety check at
세포 생존율은 도 2 및 3에 나타내었다. B16F10 세포의 경우 적미는 1, 5, 10, 50, 100 ㎍/mL의 농도에서 각각 1.58±0.09%, 1.50±0.11%, 1.44±0.16%, 1.40±0.13%, 1.30±0.17%, 흑미는 1.91±0.13%, 1.85±0.13%, 1.75±0.13%, 1.75±0.09%, 1.53±0.20%, 상황 균사 배양적미의 경우 1.51±0.07%, 1.44±0.14%, 1.40±0.12%, 1.40±0.10%, 1.35±0.07%, 상황 균사 배양흑미의 경우 1.51±0.07%, 1.44±0.14%, 1.40±0.12%, 1.40±0.10%, 1.35±0.07%로 나타났다. 따라서 적미, 흑미, 상황 균사 배양적미, 상황 균사 배양흑미에서 1, 5, 10, 50, 100 ㎍/mL의 농도에서 90%에 가까운 생존율을 나타내어 세포 독성이 없음을 확인하였다(도 2).Cell viability is shown in Figures 2 and 3. In the case of B16F10 cells, the redness was 1.58 ± 0.09%, 1.50 ± 0.11%, 1.44 ± 0.16%, 1.40 ± 0.13% and 1.30 ± 0.17% at the concentrations of 1, 5, 10, 50 and 100 ㎍ / 1.14 ± 0.12%, 1.40 ± 0.13%, 1.75 ± 0.13%, 1.75 ± 0.13%, 1.75 ± 0.09% and 1.53 ± 0.20% 1.35 ± 0.07% and 1.51 ± 0.07%, 1.44 ± 0.14%, 1.40 ± 0.12%, 1.40 ± 0.10% and 1.35 ± 0.07%, respectively. Therefore, the survival rate was close to 90% at the concentrations of 1, 5, 10, 50, and 100 ㎍ / mL in the rice cultivars of red rice, black rice,
섬유아세포(fibroblast cell)의 경우 적미는 1, 5, 10, 50, 100 ㎍/mL의 농도에서 각각 2.11±0.17%, 2.17±0.16%, 2.08±0.18%, 2.03±0.15%, 1.86±0.28%, 흑미는 2.02±0.16%, 2.02±0.16%, 2.00±0.16%, 1.98±0.16%, 1.86±0.24%, 상황 균사 배양적미의 경우 2.03±0.11%, 2.00±0.13%, 1.92±0.11%, 1.93±0.10%, 1.87±0.12%, 상황 균사 배양흑미의 경우 2.03±0.11%, 2.00±0.13%, 1.92±0.12%, 1.93±0.10%, 1.87±0.12%, 따라서 100 ㎍/mL 이하의 농도에서 90%에 가까운 생존율을 나타내어 낮은 세포 독성을 확인하였다(도 3).
At the concentration of 1, 5, 10, 50, and 100 ㎍ / mL for fibroblast cells, the redness was 2.11 ± 0.17%, 2.17 ± 0.16%, 2.08 ± 0.18%, 2.03 ± 0.15%, and 1.86 ± 0.28% , 2.02 ± 0.16%, 2.02 ± 0.16%, 2.00 ± 0.16%, 1.98 ± 0.16%, and 1.86 ± 0.24% for black rice, 2.03 ± 0.11%, 2.00 ± 0.13%, 1.92 ± 0.11% and 1.93 ± 0.24% , And the concentration of the strain was 90% at a concentration of 100 μg / mL or less, and the concentration of the strain was 2.03 ± 0.11%, 2.00 ± 0.13%, 1.92 ± 0.12%, 1.93 ± 0.10%, and 1.87 ± 0.12% %, Indicating low cytotoxicity (Fig. 3).
실시예Example 4: 수렴( 4: convergence AstringentAstringent ) 활성 확인) Active confirmation
수렴이란 뜻에는 기본적으로 주름이 지고 혹은 움츠린다는 의미가 있으며, 수렴제는 강한 단백질 결합 성질을 나타낸다. 수렴작용에는 피부와 점막의 표면에 난용성 피막을 형성하고 그 결과 국소를 보호하거나, 혹은 조직을 조밀하게 하여 세포막의 투과성을 감소시키는 효과가 있다. 본 실험에서는 헤모글로빈(hemoglobin) 단백질이 추출물과 결합하는 정도에 따라 수렴 효과를 판단하였다.Convergence means basically wrinkled or refractory, and astringent agent shows strong protein binding properties. Convergent action has the effect of forming an insoluble film on the surface of skin and mucous membranes and consequently protecting the locus or densifying the tissue to reduce the permeability of the cell membrane. In this experiment, the convergence effect was determined according to the degree of hemoglobin protein binding to the extract.
상황 균사 배양적미의 경우 5000 ㎍/mL에서 72.14±0.22%, 적미의 경우 55.06±0.64%, 상황 균사 배양흑미의 경우 93.53±2.90%, 흑미의 경우 87.96±0.95%로 대조구인 적미와 흑미보다 상황 균사 배양미에서 더 높은 활성을 보였으며, 양성대조물질인 타닌산(tannic acid)의 경우 95.52±0.72%로 상황 균사 배양미와 유사한 활성을 나타내었다(도 4).
In the case of cultivated hyphae, 72.14 ± 0.22% was observed at 5000 ㎍ / mL, 55.06 ± 0.64% at redness, 93.53 ± 2.90% in case of cultured hyphae, and 87.96 ± 0.95% The activity was higher in mycelial cultures and 95.52 ± 0.72% in the case of tannic acid, a positive control, showing similar activity to that of cultured mycelium (FIG. 4).
상기 실시예를 통해 안전성과 수렴 효과가 뛰어남을 확인한 상황버섯 균사체 배양미 추출물을 함유하는 화장료 조성물을 조성하여 제시한다. 그러나, 본 발명의 조성물을 포함하는 화장료가 하기의 제형예들로 한정되는 것은 아니다. 하기 제형예는 상황버섯 균사체 배양흑미 추출물 또는 상황버섯 균사체 배양적미 추출물을 이용할 수 있다.
A cosmetic composition containing the cultured Mythaceae mycelium extract obtained by confirming that the safety and convergence effect is excellent through the above examples is prepared and presented. However, cosmetic compositions containing the composition of the present invention are not limited to the following formulation examples. The following formulation examples can be used for the black rice extract of cultured mycelium of mycelia of mushroom or the cultivated mash extract of mushroom mycelium.
제형예Formulation Example 1: 유연화장수 1: softening longevity
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 유연화장수의 처방예는 다음과 같다.The following is an example of the formulation of softening longevity in the cosmetic containing the extract of Mycelia mushroom mycelium extract.
제형예Formulation Example 2: 수렴 화장수 2: convergent lotion
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 수렴 화장수의 제형예는 다음과 같다.Examples of formulations of convergent lotion among the cosmetic compositions containing the mushroom mycelium cultured extract are as follows.
제형예Formulation Example 3: 영양 화장수 3: Nourishing lotion
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 영양 화장수의 제형예는 다음과 같다.Examples of formulations of nutritional lotion among the cosmetic compositions containing extracts of Mycelia cultured Mycelium of mushroom are as follows.
제형예Formulation Example 4: 영양크림 4: Nourishing cream
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 영양크림의 제형예는 다음과 같다.Example of formulation of nutritional cream among cosmetics containing extract of mushroom mycelium culture extract is as follows.
제형예Formulation Example 5: 마사지 크림 5: Massage cream
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 마사지 크림의 제형예는 다음과 같다.Example of formulation of a massage cream in a cosmetic composition containing a mushroom mycelium culturing extract is as follows.
제형예Formulation Example 6: 에센스 6: Essence
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 에센스의 제형예는 다음과 같다.Examples of the formulations of the essences in the cosmetics containing the extract of the Myzanji mycelium culture are as follows.
제형예Formulation Example 7: 팩 7: Pack
상황버섯 균사체 배양미 추출물을 함유한 화장료 중 팩의 제형예는 다음과 같다.Examples of the formulations of packs in cosmetics containing extracts of Mycelium of mushroom mycelium are as follows.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120067866A KR101426232B1 (en) | 2012-06-25 | 2012-06-25 | Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120067866A KR101426232B1 (en) | 2012-06-25 | 2012-06-25 | Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140000546A KR20140000546A (en) | 2014-01-03 |
KR101426232B1 true KR101426232B1 (en) | 2014-08-05 |
Family
ID=50138405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120067866A KR101426232B1 (en) | 2012-06-25 | 2012-06-25 | Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101426232B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101628939B1 (en) | 2015-12-14 | 2016-06-09 | 백진주 | Cosmetic composition for improving atopic dermatitis and dry skin containing the botanical extracts prepared by bioconversion |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040015469A (en) * | 2002-08-13 | 2004-02-19 | 주식회사 래디안 | Cosmetic composition containing extract from phellinus linteus cultivated in rice |
-
2012
- 2012-06-25 KR KR1020120067866A patent/KR101426232B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040015469A (en) * | 2002-08-13 | 2004-02-19 | 주식회사 래디안 | Cosmetic composition containing extract from phellinus linteus cultivated in rice |
Also Published As
Publication number | Publication date |
---|---|
KR20140000546A (en) | 2014-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101997893B1 (en) | Method of increase the bioactive effectiveness of sprout ginseng | |
KR101939918B1 (en) | Fermentation method of lactic acid bacteria using paprika and its use | |
KR20170074821A (en) | Anti-Oxidant Composition Using a Fermented Materials or an Extract of Korean Dendropanax | |
US20140205626A1 (en) | Anti-inflammatory and immune-boosting composition containing fermented green coffee beans which are fermented with monascus | |
KR101142370B1 (en) | Method for producing fermented solution of mushroom with enhanced antioxidative activity and fermented solution of mushroom produced by the same | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR101197101B1 (en) | Composition for skin whitening comprising extracts of Microalgae culture medium as an active ingredient | |
KR20190061544A (en) | Cosmetic Composition for Anti-oxidation and Whitening comprising fermented silkworm extract as effective component | |
KR20110054746A (en) | A composition for skin anti-aging comprising extracts or fractions of eremochloa ophiuroides as an active ingredient | |
KR20200083293A (en) | Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera | |
KR101700872B1 (en) | Cosmetic composition comprising the very high-pressure extract of wormwood fermentation | |
KR102275055B1 (en) | Composition comprising scutellaria alpina extract | |
KR100768830B1 (en) | Extract of echinosophora koreensis removing hangover and having anti-oxidant activity | |
KR101912589B1 (en) | Composition for skin moisturizing and atopy improvement comprising fermented herbal mixture as effective component | |
KR101426232B1 (en) | Astringent cosmetic composition containing extract of rice cultivated with Phellinus baumii mycelium as effective component | |
KR101943959B1 (en) | A Method for Preparing a Fermented Product of Bamboo Leaves | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR101999374B1 (en) | Composition for Improving Atopic Dermatitis Using Fermented Products of Fruit of Diospyros kaki | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR102302072B1 (en) | Method for producing fermented Beta vulgaris extract with improved antioxidant activity and fermented Beta vulgaris extract produced by the same method | |
KR100758266B1 (en) | Extract of chrysanthemum zawadskii removing hangover and having anti-oxidant activity | |
KR101890485B1 (en) | Antioxidant Composition Using an Fermentation of Bamboo Shoot | |
KR20150037774A (en) | Preparation of clove having enhanced antioxidative effect | |
KR101817053B1 (en) | Composition for anti-oxidant or anti-cancer or anti-obesity or immune-enhancing containing Codonopsis lanceolata extract | |
KR101498075B1 (en) | Composition and health functional food containing extracts of sorghum bran |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20170524 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190513 Year of fee payment: 6 |